{"altmetric_id":4687042,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Almirall, S.A."],"first_seen_on":"2015-10-28T12:17:27+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1404331999,"links":["http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02180464?term=psoriasis&rcv_d=14&show_rss=Y"],"nct_id":"NCT02180464","pubdate":"2014-07-01T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis (Left\/Right)","type":"clinical_trial_study_record"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":4426439,"mean":4.8112999858163,"rank":3430874,"this_scored_higher_than_pct":2,"this_scored_higher_than":130313,"rank_type":"exact","sample_size":4426439,"percentile":2},"similar_age_3m":{"total_number_of_other_articles":76034,"mean":5.378283824129,"rank":46861,"this_scored_higher_than_pct":1,"this_scored_higher_than":1400,"rank_type":"exact","sample_size":76034,"percentile":1},"this_journal":{"total_number_of_other_articles":1,"mean":0,"rank":1,"this_scored_higher_than_pct":99,"this_scored_higher_than":104,"rank_type":"exact","sample_size":1,"percentile":99},"similar_age_this_journal_3m":{"total_number_of_other_articles":209,"mean":1.6024038461538,"rank":157,"this_scored_higher_than_pct":1,"this_scored_higher_than":1,"rank_type":"exact","sample_size":209,"percentile":1}}},"demographics":[],"counts":{"total":{"posts_count":1},"facebook":{"unique_users_count":1,"unique_users":["444542355641199"],"posts_count":1}},"posts":{"facebook":[{"title":"A Controlled Blind Trial With Intra-individual Left\/Right Comparison to Investigate the Efficacy and the Safety of an LAS41004 Formulation in Patients With Mild to Moderate Plaque Psoriasis","url":"https:\/\/www.facebook.com\/444542355641199\/posts\/641880969240669","license":"public","citation_ids":[4687042],"posted_on":"2014-07-02T20:13:19+00:00","summary":"#Psoriasis News A Controlled Blind Trial With Intra-individual Left\/Right Comparison to Investigate the Efficacy and the Safety of an LAS41004 Formulation in Patients With Mild to Moderate Plaque Psoriasis\n\nCondition: Mild to Moderate Stable Chronic \u2026","author":{"name":"Psoriasis News","url":"https:\/\/www.facebook.com\/444542355641199","facebook_wall_name":"Psoriasis News","image":"https:\/\/graph.facebook.com\/444542355641199\/picture","id_on_source":"444542355641199"}}]}}